The recent study by Bruno and colleagues showed that TAZ is expressed at low levels in MM and is associated with poor patient outcomes, thus highlighting the anticorrelation between TAZ and Che-1 expression, both in the mouse transgenic model developing MM (Vk*Che-1) and in MM cell lines (Fig. 1A) [10]. This evidence concerns the gene AATF and Miyoshi myopathy.